Sensient Technologies Corporation

2 days ago · marketbeat.com

Sensient Technologies NYSE: SXT reported third-quarter 2026 revenue of $455.8 million, up from $412.1 million a year earlier, as demand for natural food colors and growth across its operating groups supported results. The company said local-currency revenue increased 10%, while local-currency adjusted EBITDA rose 15% and adjusted EPS increased 18%.

2 days ago · seekingalpha.com

Sensient Technologies Corporation (SXT) Q3 2026 Earnings Call Transcript

3 days ago · zacks.com

Sensient Technologies (SXT) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $0.96 per share a year ago.

3 days ago · businesswire.com

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, today reported financial results for the third quarter ended September 30, 2026. Third Quarter Consolidated Results Reported revenue increased 10.6% to $455.8 million in the third quarter of 2026 versus last year's third quarter results of $412.1 million. On a local currency basis(1), revenue increased 10.2%. Reported operat.

3 days ago · businesswire.com

MILWAUKEE--(BUSINESS WIRE)--The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its common stock of $0.41 per share. The cash dividend will be paid on December 1, 2026, to shareholders of record on November 9, 2026. About Sensient Technologies Sensient Technologies Corporation is a leading global manufacturer and marketer of colors, flavors, and other specialty ingredients. Sensient uses advanced technologies and robust globa.

11 days ago · prnewswire.com

TAIZHOU, China, Oct. 22, 2026 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the "Company"), today announced that it will effect a share consolidation of its Class A ordinary shares, no par value per share, at a ratio of 1-for-100, effective on October 26, 2026 (the "Share Consolidation"). The Company's Class A ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on October 26, 2026.

12 days ago · prnewswire.com

TAIZHOU, China, Oct. 21, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), today announced that it has entered into a termination letter agreement with the purchasers in its registered direct offering announced on October 8, 2026 (the "Offering"). Under the termination letter agreement, the Company and the purchasers have terminated in full the additional purchase right set forth in Section 2.4 of the securities purchase agreement entered into in connection with the Offering.

17 days ago · businesswire.com

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2026 third quarter results at 8:30 a.m. CDT on Friday, October 30, 2026. Investors may access the live webcast on the Company's web site at investor.sensient.com. Alternatively, investors may join the conference call by contacting Chorus Call Inc. at (844) 492-3726 or (412) 317-1078. A webcast replay will be available on the Company's web site following the call. The call.

25 days ago · prnewswire.com

TAIZHOU, China, Oct. 8, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 8,000,000 Class A ordinary shares of the company, no par value per share (the "Shares") (or pre-funded warrants in lieu thereof), at a purchase price of $1.50 per share in a registered direct offering. The Company also agreed to issue to the same investors 8,000,000 warrants (the "Warrants") with an exercise price of $1.50 per share.

2 months ago · zacks.com

Sensient (SXT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.